Il ruolo della biologia molecolare nella diagnosi e terapia delle malattie cardiovascolari

Translated title of the contribution: The role of molecular biology in the diagnosis and treatment of cardiovascular diseases

Serena Mariotti, Carlo Capparuccia, Chiara Ripa, Fabiola Olivieri, Rosamaria Lisa, Antonio Procopio, Roberto Antonicelli

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The aim of this review is to emphasize the role of molecular biology in the diagnosis and therapy of major cardiomyopathies and cardiovascular risk factors. Therefore, we have underlined the genes responsible for or associated with these diseases while highlighting a role in the response to therapy (pharmacogenomics). Cardiovascular diseases and its related risk factors were divided into monogenic and polygenic forms. Monogenic forms are much rarer in clinical practice. However, polygenic forms along with most risk factors are of important clinical interest due to their high frequency in the general population. The added value of genetic testing is to provide an individual risk profile assessed in each patient and not only derived from epidemiological data. The prognosis of patients with the same risk profile, assessed using current clinical and medical history data, is often very different. An accurate prediction of the clinical course of cardiovascular disease in each patient will be the best therapeutic approach (tailored medicine) and will also result in a significant cost reduction for national healthcare systems (effective therapy).

Original languageItalian
Pages (from-to)730-745
Number of pages16
JournalGiornale Italiano di Cardiologia
Volume11
Issue number10
Publication statusPublished - Oct 2010

Fingerprint

Molecular Biology
Cardiovascular Diseases
Pharmacogenetics
Genetic Testing
Therapeutics
Cardiomyopathies
Medicine
Delivery of Health Care
Costs and Cost Analysis
Population
Genes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Il ruolo della biologia molecolare nella diagnosi e terapia delle malattie cardiovascolari. / Mariotti, Serena; Capparuccia, Carlo; Ripa, Chiara; Olivieri, Fabiola; Lisa, Rosamaria; Procopio, Antonio; Antonicelli, Roberto.

In: Giornale Italiano di Cardiologia, Vol. 11, No. 10, 10.2010, p. 730-745.

Research output: Contribution to journalArticle

@article{303b307eeb5a43e99e9c3e03bd0a1bbd,
title = "Il ruolo della biologia molecolare nella diagnosi e terapia delle malattie cardiovascolari",
abstract = "The aim of this review is to emphasize the role of molecular biology in the diagnosis and therapy of major cardiomyopathies and cardiovascular risk factors. Therefore, we have underlined the genes responsible for or associated with these diseases while highlighting a role in the response to therapy (pharmacogenomics). Cardiovascular diseases and its related risk factors were divided into monogenic and polygenic forms. Monogenic forms are much rarer in clinical practice. However, polygenic forms along with most risk factors are of important clinical interest due to their high frequency in the general population. The added value of genetic testing is to provide an individual risk profile assessed in each patient and not only derived from epidemiological data. The prognosis of patients with the same risk profile, assessed using current clinical and medical history data, is often very different. An accurate prediction of the clinical course of cardiovascular disease in each patient will be the best therapeutic approach (tailored medicine) and will also result in a significant cost reduction for national healthcare systems (effective therapy).",
keywords = "Cardiovascular diseases, Molecular biology",
author = "Serena Mariotti and Carlo Capparuccia and Chiara Ripa and Fabiola Olivieri and Rosamaria Lisa and Antonio Procopio and Roberto Antonicelli",
year = "2010",
month = "10",
language = "Italian",
volume = "11",
pages = "730--745",
journal = "Giornale Italiano di Cardiologia",
issn = "1827-6806",
publisher = "CEPI s.r.l.",
number = "10",

}

TY - JOUR

T1 - Il ruolo della biologia molecolare nella diagnosi e terapia delle malattie cardiovascolari

AU - Mariotti, Serena

AU - Capparuccia, Carlo

AU - Ripa, Chiara

AU - Olivieri, Fabiola

AU - Lisa, Rosamaria

AU - Procopio, Antonio

AU - Antonicelli, Roberto

PY - 2010/10

Y1 - 2010/10

N2 - The aim of this review is to emphasize the role of molecular biology in the diagnosis and therapy of major cardiomyopathies and cardiovascular risk factors. Therefore, we have underlined the genes responsible for or associated with these diseases while highlighting a role in the response to therapy (pharmacogenomics). Cardiovascular diseases and its related risk factors were divided into monogenic and polygenic forms. Monogenic forms are much rarer in clinical practice. However, polygenic forms along with most risk factors are of important clinical interest due to their high frequency in the general population. The added value of genetic testing is to provide an individual risk profile assessed in each patient and not only derived from epidemiological data. The prognosis of patients with the same risk profile, assessed using current clinical and medical history data, is often very different. An accurate prediction of the clinical course of cardiovascular disease in each patient will be the best therapeutic approach (tailored medicine) and will also result in a significant cost reduction for national healthcare systems (effective therapy).

AB - The aim of this review is to emphasize the role of molecular biology in the diagnosis and therapy of major cardiomyopathies and cardiovascular risk factors. Therefore, we have underlined the genes responsible for or associated with these diseases while highlighting a role in the response to therapy (pharmacogenomics). Cardiovascular diseases and its related risk factors were divided into monogenic and polygenic forms. Monogenic forms are much rarer in clinical practice. However, polygenic forms along with most risk factors are of important clinical interest due to their high frequency in the general population. The added value of genetic testing is to provide an individual risk profile assessed in each patient and not only derived from epidemiological data. The prognosis of patients with the same risk profile, assessed using current clinical and medical history data, is often very different. An accurate prediction of the clinical course of cardiovascular disease in each patient will be the best therapeutic approach (tailored medicine) and will also result in a significant cost reduction for national healthcare systems (effective therapy).

KW - Cardiovascular diseases

KW - Molecular biology

UR - http://www.scopus.com/inward/record.url?scp=77957946877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957946877&partnerID=8YFLogxK

M3 - Articolo

C2 - 21246774

AN - SCOPUS:77957946877

VL - 11

SP - 730

EP - 745

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 1827-6806

IS - 10

ER -